These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 1557735)
41. Cellular mechanism of action of loop diuretics: implications for drug effectiveness and adverse effects. Feig PU Am J Cardiol; 1986 Jan; 57(2):14A-19A. PubMed ID: 3511652 [TBL] [Abstract][Full Text] [Related]
42. Loop diuretics: from the Na-K-2Cl transporter to clinical use. Shankar SS; Brater DC Am J Physiol Renal Physiol; 2003 Jan; 284(1):F11-21. PubMed ID: 12473535 [TBL] [Abstract][Full Text] [Related]
43. Continuous infusion of loop diuretics in the critically ill: a review of the literature. Martin SJ; Danziger LH Crit Care Med; 1994 Aug; 22(8):1323-9. PubMed ID: 8045153 [TBL] [Abstract][Full Text] [Related]
44. [The loop diuretic bumetanide as a tool in physiology and pharmacology]. Petzinger E Dtsch Tierarztl Wochenschr; 1992 Oct; 99(10):412-5. PubMed ID: 1425319 [TBL] [Abstract][Full Text] [Related]
45. GPR35 is a target of the loop diuretic drugs bumetanide and furosemide. Yang Y; Fu A; Wu X; Reagan JD Pharmacology; 2012; 89(1-2):13-7. PubMed ID: 22236570 [TBL] [Abstract][Full Text] [Related]
46. Pharmacology, therapeutic efficacy, and adverse effects of bumetanide, a new "loop" diuretic. Flamenbaum W; Friedman R Pharmacotherapy; 1982; 2(4):213-22. PubMed ID: 6763204 [TBL] [Abstract][Full Text] [Related]
47. The role of continuous infusion loop diuretics. Yelton SL; Gaylor MA; Murray KM Ann Pharmacother; 1995 Oct; 29(10):1010-4; quiz 1060-1. PubMed ID: 8845538 [TBL] [Abstract][Full Text] [Related]
48. Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Ward A; Heel RC Drugs; 1984 Nov; 28(5):426-64. PubMed ID: 6391889 [TBL] [Abstract][Full Text] [Related]
49. Bumetanide--acute and long-term studies of a new high potency diuretic. Murdoch WR; Auld WH Postgrad Med J; 1975; 51 Suppl 6():64-69. PubMed ID: 1105535 [No Abstract] [Full Text] [Related]
50. cAMP-stimulated cation cotransport in avian erythrocytes: inhibition by "loop" diuretics. Palfrey HC; Feit PW; Greengard P Am J Physiol; 1980 Mar; 238(3):C139-48. PubMed ID: 6245581 [TBL] [Abstract][Full Text] [Related]
51. A randomized, placebo-controlled study of loop diuretics in patients with essential hypertension: the bumetanide and furosemide on lipid profile (BUFUL) clinical study report. van der Heijden M; Donders SH; Cleophas TJ; Niemeyer MG; van der Meulen J; Bernink PJ; de Planque BA; van der Wall EE J Clin Pharmacol; 1998 Jul; 38(7):630-5. PubMed ID: 9702848 [TBL] [Abstract][Full Text] [Related]
56. What to watch for when you give loop diuretics. White SJ; Williamson K RN; 1979 Dec; 42(12):25-7. PubMed ID: 261455 [No Abstract] [Full Text] [Related]
57. Loop diuretics inhibit detubulation and vacuolation in amphibian muscle fibres exposed to osmotic shock. Khan KN; Skepper JN; Hockaday AR; Burgess AJ; Huang CL J Muscle Res Cell Motil; 2000 Jan; 21(1):79-90. PubMed ID: 10813637 [TBL] [Abstract][Full Text] [Related]